Data-driven insights into the future market dynamics for nearly 40 tumors.
With a forward-looking focus on the clinical landscape, Smart Analyst Oncology Insights – a syndicated report - is the best way to understand your market opportunity, access detailed clinical data, and receive updates on the changing landscape.
Oncology is the cornerstone of our consulting business, and we have developed the series as a foundation for our clients’ key clinical and commercial development and BD&L decisions.
Updates available after major conferences – ASCO, ASCO GI, ASCO GU, AACR, ASH, EHA, ESMO, and SABCS. Additional tumors can be covered or we can customize reports, as required.
Senior Commercial and Strategy Director
Brendan has over 20 years’ of progressive experience serving as a partner to stakeholders in life sciences, pharmaceutical, biotech and healthcare. His research experience spans all facets of qualitative and quantitative primary market research, competitive intelligence, secondary and syndicated research.